| Fri, 21 Jul 2017 13:30:19: | Aeterna CEO Dodd out as company reviews options
|
| Fri, 21 Jul 2017 12:09:27: | News of Note—Biotech IPOs; CHMP knockbacks
|
| Fri, 21 Jul 2017 11:35:32: | MHRA to move HQ to same area as EMA’s London digs
|
| Thu, 20 Jul 2017 20:09:46: | Targeting inflammation could treat metabolic syndrome's many symptoms
|
| Thu, 20 Jul 2017 15:50:51: | Ironwood slips as heartburn data underwhelm investors
|
| Thu, 20 Jul 2017 14:44:32: | Attacking muscle diseases like ALS by clearing protein clumps
|
| Thu, 20 Jul 2017 13:46:11: | News of Note—Trevena CMO exit; AMO deal; Kala IPO; AliveCor-Mayo pact
|
| Thu, 20 Jul 2017 12:33:52: | Sanofi offers Ablynx billions of biobucks for nanobody partnership
|
| Thu, 20 Jul 2017 12:03:42: | Roche dumps Oryzon’s epigenetic AML, solid tumor drug
|
| Thu, 20 Jul 2017 10:27:39: | Theravance COPD drug clears safety study, setting up NDA
|
| Thu, 20 Jul 2017 09:22:43: | Novartis, Sanofi-backed NeuroVia closes $14M series A for X-ALD work
|
| Wed, 19 Jul 2017 14:09:56: | News of Note—Dodgy stem cell clinics; New CMO for Context; UroGen payday
|
| Wed, 19 Jul 2017 13:14:07: | EU watchdog asks if drugmakers influence EMA decisions
|
| Wed, 19 Jul 2017 12:24:15: | Lilly firms up Adimab R&D alliance, bringing its Ab platform in-house
|
| Wed, 19 Jul 2017 09:51:03: | Japan’s Fujifilm sees phase 2 flop for Alzheimer’s candidate
|
| Wed, 19 Jul 2017 09:28:37: | Vertex cystic fibrosis drugs ace clinical trials, sparking 26% stock price surge
|
| Tue, 18 Jul 2017 14:06:24: | News of Note—Nektar’s sweet data; Zymeworks bonus; Alzheimer’s pipeline
|
| Tue, 18 Jul 2017 12:40:23: | Shire pens bispecific hemophilia R&D deal with Novimmune
|
| Tue, 18 Jul 2017 12:32:55: | Kleo taps PeptiDream for help with immuno-oncology programs
|
| Tue, 18 Jul 2017 12:15:17: | Abzena licenses PSMA antibodies to Telix to create cancer-targeting radioactive drugs
|
| Tue, 18 Jul 2017 08:16:17: | Paratek antibiotic hits endpoints in phase 3, teeing up NDA
|
| Mon, 17 Jul 2017 12:50:40: | CymaBay takes a peek at liver disease candidate data
|
| Mon, 17 Jul 2017 12:29:29: | Backers put $12.7M behind Enterin's Parkinson's disease approach
|
| Mon, 17 Jul 2017 12:22:32: | U.K. commits £86M to get medical advances into NHS faster
|
| Mon, 17 Jul 2017 08:18:13: | Safety scare prompts FDA to reject Amgen’s romosozumab
|
